Tirzepatide
Sold by Health Source Online · Injection · device not recorded · every tirzepatide record
The program identifies an injection, but the delivery device has not been established.
Price
| Term | Published rate | Charged today |
|---|---|---|
| Full Dose; displayed recurring charge Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. “$299.00 every 4 weeks” | $299Published figure | Charged todayNot verified |
| Starter Dose 6 weeks; displayed recurring charge Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. “$299.00 every 4 weeks” | $299Published figure | Charged todayNot verified |
| Starter Dose 4 weeks; displayed recurring charge Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. “$299.00 every 4 weeks” | $299Published figure | Charged todayNot verified |
| 8 Weeks; displayed recurring charge Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. “$549.00 every 8 weeks” | $549Published figure | Charged todayNot verified |
Price sources
- Full Dose; displayed recurring charge · healthsource.online — read October 2026
- Starter Dose 6 weeks; displayed recurring charge · healthsource.online — read October 2026
- Starter Dose 4 weeks; displayed recurring charge · healthsource.online — read October 2026
- 8 Weeks; displayed recurring charge · healthsource.online — read October 2026
We earn nothing from this link. It opens Health Source Online's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Both |
| Cancellation | Cancel renewal through account settings; already processed charges are described as nonrefundable. The refund policy variously uses pharmacy transmission, processing and shipping cutoffs. The separate payment policy permits pre-shipping refunds, retains $25–$45 after intake completion, and promises full refund for nonapproval. Product pages also promise auto-refund if monthly reassessment is missing. These differing scopes are unresolved; confirm before paying. https://healthsource.online/return-and-refund-policy/ https://healthsource.online/payment-policy/ |
| Membership | Not disclosed |
| Consult fee | Not disclosed |
Recorded from healthsource.online. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Prices are explicitly all-inclusive, not a membership: 'Every one of our programs covers the cost of medication, supplies, and provides 24/7 access to your care team.' Prescriber marked 'sync' on the strength of 'same-day telehealth consultations to thoroughly evaluate your health data' (a live physician evaluation), though the exact video-vs-phone-vs-messaging format is not spelled out. Also sells Addyi, sildenafil/tadalafil, Upneeq eye drops, and various peptide/NAD+ products (not entered, not GLP-1s).
- 2. October 2026 — The public service-area page advertises all 50 states, excluding territories and international patients; it does not identify medication-specific availability. The prescription policy requires local licensure. No named dispensing pharmacy is established. https://healthsource.online/service-areas/ https://healthsource.online/prescription-policy/
- 3. October 2026 — Consultation and ongoing support appear in the program, but separate fee allocation is unclear. Completing intake is described as consultation/review for a $25–$45 refund retention; this is not assumed to be an additional universal fee. The terms describe video/audio consultation options alongside intake review; a live video visit is not established as mandatory. https://healthsource.online/payment-policy/ https://healthsource.online/terms-of-use/
- 4. October 2026 — Cancel renewal through account settings; already processed charges are described as nonrefundable. The refund policy variously uses pharmacy transmission, processing and shipping cutoffs. The separate payment policy permits pre-shipping refunds, retains $25–$45 after intake completion, and promises full refund for nonapproval. Product pages also promise auto-refund if monthly reassessment is missing. These differing scopes are unresolved; confirm before paying. https://healthsource.online/return-and-refund-policy/ https://healthsource.online/payment-policy/
- 5. October 2026 — The selected public options publish charges every four or eight weeks, not calendar months. No cart, private medical intake or payment was submitted. A displayed recurring rate does not establish the full initial invoice. https://healthsource.online/product/tirzepatide-weight-loss-program/
- 6. October 2026 — The reviewed product identifies tirzepatide but does not explicitly establish a brand or compounded formulation. The prior compounded classification is refined to the named ingredient, without asserting a change in what is sold. https://healthsource.online/product/tirzepatide-weight-loss-program/
5 further notes concern other Health Source Online programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.